Skip survey header

2018 3HP Provider Guidance Download

Thank you for your interest in NTCA's guidance for healthcare providers considering use of the 3HP regimen for treatment of latent TB infection: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI).

Please note that we are collecting minimal contact information to conduct an evaluation to learn how this resource is being utilized and by whom.
1. Please enter your name and email address. *This question is required.